Associations of Alzheimer's disease with macular degeneration

Area of Science:

• Neuroscience and Ophthalmology
• Investigates the intersection of neurodegenerative and ocular diseases.

Background:

• Growing evidence links Alzheimer's disease (AD) and age-related macular degeneration (AMD) epidemiologically, genetically, and clinically.
• Beta-amyloid, central to AD pathology (senile plaques), is also found in AMD drusen, suggesting a shared molecular target.
• Both diseases are influenced by common pathophysiological factors including oxidative stress and neuroinflammation.

Purpose of the Study:

• To review and synthesize the pathophysiological and clinical evidence connecting Alzheimer's disease and age-related macular degeneration.
• To highlight the therapeutic potential of targeting shared pathways, particularly beta-amyloid, for both AD and AMD.

Main Methods:

• Review of existing epidemiological, genetic, molecular, and clinical studies.
• Analysis of the role of beta-amyloid in the pathology of both AD and AMD.
• Examination of shared risk factors such as oxidative stress and neuroinflammation.
• Consideration of clinical trials evaluating antioxidants for co-occurring AD and AMD.

Main Results:

• Beta-amyloid is a key shared component in the hallmark pathologies of both AD (senile plaques) and AMD (drusen).
• Oxidative stress and neuroinflammation are identified as common pathophysiological mechanisms contributing to both diseases.
• Preliminary clinical trials suggest potential benefits of antioxidants in patients with both AD and AMD.

Conclusions:

• The shared molecular and pathophysiological basis between AD and AMD presents significant opportunities for novel therapeutic strategies.
• Targeting beta-amyloid and mitigating oxidative stress/neuroinflammation could offer combined treatment benefits for these prevalent age-related disorders.
• Further research is crucial given the increasing prevalence of both conditions and the aging global population.